OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-10-31-accounts

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Company Registration Number: NI070807 Charity Registration Number: 101272

Charis Cancer Care Ltd (Charitable Company Limited by Guarantee)

Annual Report and Audited Financial Statements For the year ended 31 October 2023

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd (Charitable Company Limited by Guarantee)

CONTENTS For the year ended 31 October 2023

Page
General Information 2
Directors’ Report 3 – 5
Independent Auditor’s Report 6 – 9
Consolidated Statement of Financial Activities 10
Consolidated Statement of Financial Position 11
Company Statement of Financial Position 12
Consolidated Statement of Cash Flows 13
Notes to the Financial Statements 14 – 28

CavanaghKelly, Chartered Accountants & Statutory Auditors Page 1

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

GENERAL INFORMATION

Board of Directors Jarlath Conway (resigned 7 November 2023) Steven McKay Dr Ben Glancy Thomas Diamond Kirsty McManus David Henry Peter Stafford Professor Marie Louise McHugh Roisin Toner Registered Office 163 Lough Fea Road Ballybreist Cookstown Co. Tyrone BT80 9TU Company Registration Number NI070807 Charity Registration Number 101272 Independent Auditors CavanaghKelly Chartered Accountants and Statutory Auditors 36 - 38 Northland Row Dungannon Co. Tyrone BT71 6AP Solicitors P.A. Duffy & Co 27-29 Broad St Magherafelt Co. Londonderry BT45 6EB Bankers Bank of Ireland Market Street Magherafelt Co. Londonderry BT45 6EE

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 2

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

DIRECTORS’ REPORT for the year ended 31 October 2023

The Directors, who are the trustees for the purpose of charity law, have pleasure in presenting
their report and the audited financial statements of the charitable company for the year ended 31
October 2023.

The financial statements have been prepared in accordance with the Statement of Recommended
Practice “Accounting and Reporting by Charities” (FRS 102), United Kingdom Generally Accepted
Accounting Practice and the Companies Act 2006.

Reference and Administration Details

The reference and administration details of the charitable company are as shown on page 2.

The Chief Executive was responsible for the supervision of the day-to-day operations of the
charitable company throughout the year.

Objectives and Activities

The main function of the charity is to provide complimentary cancer treatments to the people of
Northern Ireland. These services are provided free and include families of people affected by
cancer.

Charis Cancer Care Ltd works in conjunction with clinical treatments for cancer and our comfortable
treatment rooms are purpose-designed for the delivery of complementary therapies by trained
practitioners free of charge. Individual and group therapies are available. Treatments provided to
Cancer Care Patients include massage, relaxation aromatherapy, reflexology, yoga, financial
planning and dietary support.

Public Benefit Statement

The Directors of Charis Cancer Care Ltd confirm that they have complied with their duty under
section 4(6) of the Charities Act (Northern Ireland) 2008 to have regard to the Charity Commission
for Northern Ireland’s guidance on public benefit and that the public benefit requirement has
informed the activities of the charitable company in the year ended 31 October 2023.

Achievements and Performance

The Board of Directors are confident the charity continues to meet its performance objectives and
continues to receive excellent feedback from clients. The centre provides a high-quality service to
clients from all over Northern Ireland. During the year ended 31 October 2023, 1,256 new clients
availed of the services provided by the Charity, bringing the total number of clients assisted to date
to 12,018.

Financial Review

Financial Performance

The financial performance was in line with Directors’ expectations. The charitable group remains in
a sound financial position at the year end. The results for the year are set out in details on pages 9
to 27. The group had net incoming resources for the year of £52,400 (2022 – £83,072 of outgoing
resources).

At 31 October 2023, the total funds of the group amounted to £1,254,115 (2022: £1,201,715).
The total charity funds amounted to £1,154,993 (2022 - £1,148,353) Principal sources of funding
and how this has supported the key objectives of the charity are disclosed in the notes to the
financial statements.

__________________

CavanaghKelly, Chartered Accountants & Statutory Auditors

Page 3

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

DIRECTORS’ REPORT for the year ended 31 October 2023 (Continued)

Financial Review (Continued)

Reserves Policy

In the prior year, the Board of Directors implemented two additional funds to the charity’s
unrestricted funds to help control and monitor everyday running costs as well as for future capital
projects. This seen the implementation of a Capital Fund and a Designated Fund as noted below.

Unrestricted Funds:

– Capital Funds Funds earmarked for future capital projects to assist with the expansion of the charity. Such capital projects are currently being researched by the Board of Directors.

Designated Funds – Monies which have been set aside to cover costs should there be a significant and unforeseen reduction in funding.

General Funds – Funds which are expendable at the discretion of the Directors in furtherance of the objectives of the charity.

Restricted Funds – Income received for specific purposes. Such purposes are within the overall aims of the charity.

Structure, Governance and Management

Organisational Structure

The charitable company is a company limited by guarantee, not having a share capital.

The charitable company was established under a Memorandum of Association which established the
objects and powers of the charitable company and is governed under its Articles of Association.

In accordance with the Articles of Association, the members to retire by rotation shall be those who
have been longest in office since their last election, and the relevant motion will be put at the
Annual General Meeting. A retiring member shall be eligible for re-election.

The charitable company is governed by the Board of Trustees. None of the Trustees have any
beneficial interest in the charitable company. Any person wishing to become a director must apply
in writing prior to the annual general meeting. A vote is then taken at the annual general meeting
as to whether that person is appointed.

Directors

The Directors during the year are the same as the Directors as listed on page 2.

Taxation Status

The charitable company is recognised as a charity by HM Revenue & Customs. Accordingly, the
charitable company has availed of the exemptions contained in Chapter 3 Part 11 Corporation
Taxes Act 2010 and Section 256 Taxation of Chargeable Gains Act 1992.

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors 

Page 4

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

DIRECTORS’ REPORT for the year ended 31 October 2022 (Continued)

Directors' Responsibilities

The Directors are responsible for preparing the Directors’ Report and the financial statements in
accordance with applicable law and United Kingdom Accounting Standards (United Kingdom
Generally Accepted Accounting Practice).

Company law requires the Directors to prepare financial statements for each financial year, which
give a true and fair view of the state of affairs of the charitable company and of the incoming
resources and application of resources, including the income and expenditure, of the charitable
company for that period. In preparing these financial statements, the trustees are required to:

The Directors are responsible for keeping adequate accounting records that disclose with
reasonable accuracy at any time the financial position of the charitable company and enable them
to ensure that the financial statements comply with the Companies Act 2006. They are also
responsible for safeguarding the assets of the charitable company and hence for taking reasonable
steps for the prevention and detection of fraud and other irregularities.

Statement of Disclosure of Information to Auditor

In so far as the Directors, who held office at the date of approval of these financial statements, are
aware:

Small Companies Exemption

This report is prepared in accordance with the special provisions relating to small companies within
Part 15 of the Companies Act 2006.

This report was approved by the Board of Directors on 25 March 2024 and signed on its behalf by:

Registered office:

Registered office:
163 Lough Fea Road
Ballybreist _________________ _________________
Cookstown Professor Marie Louise McHugh David Henry
BT80 9TU Director Director

Company Registration Number: NI070807 Charity Registration Number: 101272

__________________

CavanaghKelly, Chartered Accountants & Statutory Auditors Page 5

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

INDEPENDENT AUDITORS’ REPORT to the Directors of Charis Cancer Care Ltd for the year ended 31 October 2023

Opinion

We have audited the financial statements of Charis Cancer Care Ltd ('the charitable company') for
the year ended 31 October 2023 which comprise the Statement of Financial Activities, the
Statement of Financial Position, the Statement of Cash Flows and the related notes to the financial
statements, including a summary of significant accounting policies. The financial reporting
framework that has been applied in their preparation is applicable law and United Kingdom
Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK
and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

This report is made solely to the charitable company’s Directors, as a body, in accordance with
Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we
might state to the charitable company’s Directors those matters we are required to state to them
in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not
accept or assume responsibility to anyone other than the charitable company and the charitable
company’s Directors as a body, for our audit work, for this report, or for the opinions we have
formed.

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK))
and applicable law. Our responsibilities under those standards are further described in the Auditor's
responsibilities for the audit of the financial statements section of our report. We are independent
of the company in accordance with ethical requirements that are relevant to our audit of the
financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other
ethical responsibilities in accordance with these requirements. We believe that the audit evidence
we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which ISAs (UK) require
us to report to you where:

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 6

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

INDEPENDENT AUDITORS’ REPORT to the Directors of Charis Cancer Care Ltd for the year ended 31 October 2023 (Continued)

Other information

The directors are responsible for the other information. The other information comprises the
information included in the Directors’ Report, other than the financial statements and our Auditor's
Report thereon. Our opinion on the financial statements does not cover the other information and,
except to the extent otherwise explicitly stated in our report, we do not express any form of
assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other
information and, in doing so, consider whether the other information is materially inconsistent with
the financial statements, or our knowledge obtained in the audit, or otherwise appears to be
materially misstated. If we identify such material inconsistencies or apparent material
misstatements, we are required to determine whether there is a material misstatement in the
financial statements or a material misstatement of the other information. If, based on the work we
have performed, we conclude that there is a material misstatement of this other information, we
are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the charitable company and its environment
obtained in the course of the audit, we have not identified material misstatements in the Directors’
Report.

We have nothing to report in respect of the following matters in relation to which the Companies
Act 2006 requires us to report to you if, in our opinion:

Responsibilities of Directors

As explained more fully in the Directors’ Responsibilities Statement, the directors (who are also the
trustees of the charitable company for the purpose of charity law), are responsible for the
preparation of the financial statements and for being satisfied that they give a true and fair view,
and for such internal control as the Directors determine is necessary to enable the preparation of
financial statements that are free from material misstatement, whether due to fraud or error.

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors 

Page 7

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

INDEPENDENT AUDITORS’ REPORT to the Directors of Charis Cancer Care Ltd for the year ended 31 October 2023 (Continued)

Responsibilities of Directors (Continued)

In preparing the financial statements, the directors are responsible for assessing the company's
ability to continue as a going concern, disclosing, as applicable, matters related to going concern
and using the going concern basis of accounting unless the directors either intends to liquidate the
charitable company or to cease operations, or has no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a
whole are free from material misstatement, whether due to fraud or error, and to issue an
Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance but is
not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material
misstatement when it exists. Misstatements can arise from fraud or error and are considered
material if, individually or in aggregate, they could reasonably be expected to influence the
economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is
detailed below:

Irregularities, including fraud, are instances of non-compliance with laws and regulations. The
objectives of our audit in respect of fraud are to assess the risk of material misstatement due to
fraud, design and implement appropriate responses to those assessed risks and to respond
appropriately to instances of fraud or suspected fraud identified during the course of our audit.
However, the primary responsibility for the prevention and detection of fraud rests with
management and those charged with governance of the charity.

In identifying and assessing risks of material misstatement in respect of irregularities, including
fraud and non-compliance with laws and regulations, our procedures included the following:

The audit response to risks identified included:

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 8

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

INDEPENDENT AUDITORS’ REPORT to the Directors of Charis Cancer Care Ltd for the year ended 31 October 2023 (Continued)

In addressing the risk of fraud through management override of controls, testing the
appropriateness of journal entries and other adjustments, assessing whether the judgements made
in making accounting estimates are reasonable and evaluating the business rationale of any
significant transactions that are unusual or outside the normal course of business.

A further description of our responsibilities for the audit of the financial statements is located on
the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This
description forms part of our auditor’s report.

Use of our Report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of
Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to
the company's members those matters we are required to state to them in an auditor's report and
for no other purpose. To the fullest extent permitted by law, we do not accept or assume
responsibility to anyone other than the company and the company's members as a body, for our
audit work, for this report, or for the opinions we have formed.

_______________________________

Mr. Ryan Falls FCA (Senior Statutory Auditor) For and on behalf of

CAVANAGHKELLY

Chartered Accountants and Statutory Auditors
36 – 38 Northland Row
Dungannon
Co. Tyrone
BT71 6AP

Date: 25 March 2024

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 9

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES

(Including an income & expenditure account) For the year ended 31 October 2023

ncung an ncome expenture ac
or the year ended 31 October 2023		 count)
Income and Endowments
Donations and legacies (Note 3)
Other trading income (Note 3)
Investment Income
Grant Income
Income from Other Trading
Activities
Commercial Trading Operations (Note 4)
Total Income and Endowments
Resources Expended
Charitable Activities (Note 5)
Commercial Trading Operations (Note 4)
Total Resources Expended
Tax charge on Commercial Trading
Operations (Note 8)
Net incoming/(outgoing) resources
for the year
Balance brought forward
Transfer between funds
Balance carried forward		 Unrestricted Funds
Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
-
224,289
-
224,289
219,454
-
-
585
-
585
333
-
-
11,932
-
11,932
3
-
-
-
305,998
305,998
151,683
-
-
203,075
-
203,075
176,636
-
-
439,881
305,998
745,879
548,109
-
-
(310,775)
(225,390)
(536,165)
(452,334)
-
-
(157,314)
-
(157,314)
(178,847)
-
-
(468,089)
(225,390)
(693,479)
(631,181)
-
-
-
-
-
-
-
-
(28,208)
80,608
52,400
(83,072)
-
250,000
762,428
189,287
1,201,715
1,284,787
-
-
-
-
-
-
-
250,000
734,220
269,895
1,254,115
1,201,715		 
The above Statement of Financial Activities includes all information as required to be disclosed by the Companies Act 2006.

All of the activities of the charitable company are classed as continuing.
The Statement of Financial Activities includes all gains and losses recognised during the year.
The notes on pages 14 to 28 form an integral part of the financial statements.

___________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 10

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

CONSOLIDATED STATEMENT OF FINANCIAL POSITION as at 31 October 2023

Note
Fixed Assets
Property, Plant and Equipment
8
Investments
9
Current Assets
Receivables
10
Cash and Cash Equivalents
Payables: amounts falling due within
one year
11
Net Current Assets
Net Assets
Represented by:
Unrestricted Funds:
Capital Funds
13
Designated Funds
13
General Funds
13
Restricted Funds
13
Total Funds		 2023
2022
£
£
437,546
450,273
-
-
437,546
450,273
15,976
18,385
819,179
763,063
835,155
781,448
(18,586)
(30,006)
816,569
751,442
1,254,115
1,201,715
-
-
250,000
250,000
734,220
762,428
269,895
189,287
1,254,115
1,201,715

These financial statements have been prepared in accordance with the provisions applicable to small companies’ regime within Part 15 of the Companies Act 2006.

The notes on pages 14 to 28 form an integral part of the financial statements.

These financial statements were approved and authorised for issue by the Board of Directors on 25 March 2024 and signed on their behalf by:

____ ____ Professor Marie Louise McHugh David Henry Director Director

Company Registration Number: NI070807 Charity Registration Number: 101272

_______________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 11

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

COMPANY STATEMENT OF FINANCIAL POSITION as at 31 October 2023

Note
Fixed Assets
Property, Plant and Equipment
8
Investments
9
Current Assets
Receivables
10
Cash and Cash Equivalents
Payables: amounts falling due within
one year
11
Net Current Assets
Net Assets
Represented by:
Unrestricted Funds:
Capital Funds
13
Designated Funds
13
General Funds
13
Restricted Funds
13
Total Funds
13		 2023
2022
£
£
433,900
442,849
1
1
433,901
442,850
12,529
101,274
722,604
631,489
735,133
732,763
(14,041)
(27,260)
721,092
705,503
1,154,993
1,148,353
£
£
-
-
250,000
250,000
635,098
709,066
269,895
189,287
1,154,993
1,148,353

These financial statements have been prepared in accordance with the provisions applicable to small companies’ regime within Part 15 of the Companies Act 2006.

The notes on pages 14 to 28 form an integral part of the financial statements.

These financial statements were approved and authorised for issue by the Board of Directors on 25 March 2024 and signed on their behalf by:

____ ____ Professor Marie Louise McHugh David Henry Director Director

Company Registration Number: NI070807 Charity Registration Number: 101272

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 12

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

CONSOLIDATED STATEMENT OF CASH FLOWS

For the year ended 31 October 2023

Charis Cancer Care Ltd
(Charitable Company Limited by Guarantee)
CONSOLIDATED STATEMENT OF CASH FLOWS
For the year ended 31 October 2023
Cash flows from operating activities
Surplus/(Deficit) for the year
Adjustments for:
Depreciation
Amortisation of government grants
Profit on disposal of freehold property
Movements in working capital:
Movement in receivables
Movement in payables
Net cash generated from operating activities
Cash flows from investing activities
Payments to acquire property, plant and equipment
Receipts from disposals of property, plant and equipment
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of financial year
Cash and cash equivalents at end of financial year
Cash and cash equivalents consist of:
Cash at bank and in hand		 2023
2022
£
£
52,400
(83,072)
21,327
21,577
-
-
-
-
73,727
(61,495)
2,409
(2,309)
(11,420)
(102,770)
(9,011)
(105,079)
64,716
(166,574)
(8,600)
(13,507)
-
-
56,116
(180,081)
763,063
943,144
819,179
763,063
2023
2022
£
£
819,179
763,063

_______________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 13

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS For the year ended 31 October 2023

1. GENERAL INFORMATION

Charis Cancer Care Ltd is a charitable company limited by guarantee incorporated in Northern Ireland. In the event of the charitable company being wound up, the liability in respect of the guarantee is limited to £1 per member of the charitable company. The address of the registered office is as shown on page 2.

The charitable company constitutes a public benefit entity as defined by FRS 102.

2. ACCOUNTING POLICIES

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the charitable company’s financial statements.

2.1 Statement of Compliance

The financial statements have been prepared in accordance with Accounting and Reporting by Charites: Statement of Recommended Practice (SORP) applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) effective 1 January 2019 (Second Edition), the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) and the Companies Act 2006.

2.2 Basis of Preparation

The financial statements are prepared on a going concern basis under the historical cost convention unless otherwise stated in the relevant accounting policy. Historical cost is generally based on the fair value of the consideration given in exchange for assets. The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the charitable company's financial statements.

2.3 Group Financial Statements

The financial statements consolidate the results of the charity and its subsidiary, Friends of Charis Limited.

2.4 Income and Endowments

(i) Donations and Legacies

Donations and Legacy income includes gifts, donations and grants and is recognised in full in the Statement of Financial Activities when evidence to entitlement is obtained.

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 14

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023

2. ACCOUNTING POLICIES (Continued)

2.4 Income and Endowments (Continued)

(ii) Other Trading Income

Activities for generating funds are commercial activities which are recognised as earned when the related goods and services are provided.

(iii) Commercial Trading Income

Trading income represents the invoiced value of goods supplied during the year excluding value added tax. Revenue is recognised upon provision of the service to the customer.

2.5 Resources Expended

Expenditure is recognised when a liability is incurred. Contractual arrangements and performance related grants are recognised as goods and services are supplied. Where costs cannot be directly attributed to a particular heading they have been allocated to activities on a basis consistent with use of resources. Staff costs and overhead expenses are allocated to activities on the basis of staff time spent on those activities.

(i) Charitable Activities

This compromises all the resources applied by the charity in undertaking its work to meet its charitable objectives. Charitable activities will include the costs of governance arrangements which relate to the general running of the charity.

2.6 Fund Accounting

The charity has four types of funds for which it is responsible at the year-end:

Capital Funds – Funds earmarked for future capital projects to assist with the expansion of the charity. Such capital projects are currently being researched by the Board of Directors.

Designated Funds - Funds held in reserve to cover any future reductions in funding and allow the charity to continue to meet its obligations to staff and creditors.

Unrestricted Funds – Funds which are expendable at the discretion of the Directors in furtherance of the objectives of the charity.

Restricted Funds – Income received for specific purposes. Such purposes are within the overall aims of the charity.

_______________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 15

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023

2. ACCOUNTING POLICIES (Continued)

2.7 Property, Plant and Equipment and Depreciation

All property, plant and equipment are initially recorded at cost. Cost includes the original purchase price, costs directly attributable to bringing the asset to its working condition for its intended use, dismantling and restoration costs and borrowing costs capitalised.

Depreciation is provided at rates calculated to write off the cost less residual value of each asset over its expected useful life, as follows:

Land and Buildings 2% Straight line
Office Equipment 20% Straight line
IT Equipment 25% Straight line
Fixtures and Fittings 20% Straight line
Motor Vehicles 20% Straight line

2.8 Cash and Cash Equivalents

Cash and cash equivalents includes cash in hand, deposits held at call with banks, other shortterm highly liquid investments with original maturities of three months or less.

2.9 Investments

Investments in subsidiaries are valued at cost less provision for impairment. Income from investments together with any related tax credit is recognised in the statement of financial activities in the year in which it is receivable.

2.10 Trade and Other Receivables

Trade and other receivables are initially recorded at fair value and thereafter stated at cost less impairment losses for bad and doubtful debts.

2.11 Trade and Other Payables

Trade and other payables are initially recognised at fair value and thereafter stated at cost.

2.12 Taxation

As a charity, the charitable company is not liable to Corporation Tax. The trading subsidiary is however liable to corporation tax.

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date.

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 16

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements.

Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

2.13 Critical accounting estimates and judgements

In the application of the Charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements in applying the entity’s accounting policies There are no critical judgements in applying the group’s accounting policies.

Critical accounting estimates and assumptions

There are no accounting estimates in applying the group’s accounting policies.

2.14 Pension and other post retirement obligations

The charity operates a defined contribution pension scheme which is a pension plan under which fixed contributions are paid into a pension fund and the charity has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current or prior periods.

Contributions to defined contribution plans are recognised in the Statement of Financial Activities when they are due. If contribution payments exceed the contribution due for the service, the excess is recognised as a prepayment.

2.15 Financial Instruments

(i) Financial assets

Basic financial assets, including trade and other receivables, cash and bank balances and amounts owed by related parties and are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method.

_______________

CavanaghKelly, Chartered Accountants & Statutory Auditors Page 17

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.

If there is decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

(ii) Financial liabilities

Basic financial liabilities, including trade and other payables, bank loans and overdrafts and amounts owed to related parties are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Fees paid on the establishment of loan facilities are recognised as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs.

To the extent there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalised as a pre-payment for liquidity services and amortised over the period of the facility to which it relates.

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

(iii) Offsetting

Financial assets and liabilities are offset, and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

_______________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 18

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued)

For the year ended 31 October 2023

2.16 Exemptions under FRS 102

The charity has taken advantage of the following exemption:

(i) From preparing a cash flow statement, on the basis that it is a qualifying entity, and the consolidated statement of cash flow includes the charity’s cash flows.

2.17 Exemptions under Companies Act 2006

The charity has taken advantage of the following exemption:

_______________ CavanaghKelly, Chartered Accountants & Statutory Auditors

Page 19

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd (Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023

3. INCOME AND ENDOWMENTS

Unrestricted Funds


or the year ended 31 October
. INCOME AND ENDOWMENTS		 (onnue)
2023
Unrestricted Funds
Donations and Endowments
Client Donations
Fundraising – voluntary income
HMRC Gift Aid
Total Donations and
Endowments		 Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
-
178,684
-
178,684
180,577
-
-
45,605
-
45,605
33,872
-
-
-
-
-
5,005
-
-
224,289
-
224,289
219,454		 
Income from donations and endowments in the year ended 31 October 2022 of £219,454 was made up entirely of monies from unrestricted income.

Unrestricted Funds

Unrestricted Funds
Other Trading Activities
Books, pens and CDs
Mentoring income
Total Income from Other
Trading Activities		 Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
-
351
-
351
333
-
-
234
-
234
-
-
-
585
-
585
333		 
Income from other trading activities in the year ended 31 October 2022 of £333 was made up entirely of monies from unrestricted income.

___________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 20

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd (Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the year ended 31 October 2023

3. INCOME AND ENDOWMENTS

Unrestricted Funds

. INCOME AND ENDOWMENTS Unrestricted Funds
Investment Income
Bank Interest Receivable
Total Investment Income		 Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
-
11,932
-
11,932
3
-
-
11,932
-
11,932
3		 
Income investment income in the year ended 31 October 2022 of £3 was made up entirely of monies from unrestricted income.

3. INCOME AND ENDOWMENTS

Unrestricted Funds

. INCOME AND ENDOWMENTS Unrestricted Funds
Grant Income
Department of Health – Community
Foundation
Other grants received in the year
Total Grant Income		 Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
305,998
305,998
104,383
-
-
-
-
-
47,300
-
-
-
305,998
305,998
151,683		 
Grant income received in the year ended 31 October 2022 amounting to £151,683 was made up of £1,000 general funds and £150,683 restricted
funds.

___________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 21

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023

4. INCOME FROM OTHER TRADING ACTIVITIES

The trading subsidiary of the charity is Friends of Charis Limited. The company is incorporated in Northern Ireland within the United Kingdom (company number NI605705).

Registered Address of Subsidiary:

163 Lough Fea Road Ballybreist Cookstown Co. Tyrone BT80 9TU

Friends of Charis Limited

Friends of Charis Limited
Turnover
Cost of Sales
Administrative Expenses
Donation to Charis Cancer Care
Other Income
Tax on profit/(loss)
Net Profit/(loss)
Aggregate Share Capital and Reserves		 2023
2022
£
£
203,075
176,336
(92,089)(103,998)
(65,225)
(74,849)
-
-
-
300
-
-
45,761
(2,211)
99,123
53,362

Included within Friends of Charis Ltd financials above is a donation to Charis Cancer Care Limited of £nil (2022: £nil). This donation is accounted for as income in the parent company but is removed within the Statement of Financial Activities on consolidation under the SORP requirements.

___________________

CavanaghKelly, Chartered Accountants & Statutory Auditors Page 22

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd (Charitable Company Limited by Guarantee)

5. RESOURCES EXPENDED

Unrestricted Funds

. RESOURCES EXPENDED Unrestricted Funds
Charitable Activities
Therapists
Wages and salaries (incl pension
contributions)
Fundraising costs
Insurance
Heat and light
Motor expenses
Advertising
Repairs and maintenance
Cleaning
Computer costs
Staff training
Subscriptions
Telephone and internet
Printing, postage and stationery
Audit and accountancy
Legal and professional fees
Consultancy
General expenses
Bank charges
Depreciation
Total Resources Expended		 Capital
Funds
Designated
Funds
General Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
-
90,615
140,677
231,292
189,446
-
-
120,953
69,865
190,818
163,854
-
-
3,009
-
3,009
2,236
-
-
5,047
-
5,047
4,567
-
-
9,814
1,753
11,567
7,592
-
-
2,019
-
2,019
1,028
-
-
1,298
-
1,298
828
-
-
3,203
3,992
7,195
4,921
-
-
6,266
-
6,266
4,345
-
-
9,285
-
9,285
13,770
-
-
1,189
2,250
3,439
750
-
-
466
-
466
288
-
-
5,342
-
5,342
5,380
-
-
6,506
3,177
9,683
8,202
-
-
7,441
-
7,441
8,294
-
-
21,808
-
21,808
1,410
-
-
-
-
-
3,238
-
-
2,278
76
2,354
14,084
-
-
287
-
287
302
-
-
13,949
3,600
17,549
17,799
-
-
310,775
225,390
536,165
452,334

Expenditure on charitable activities in the year ended 31 October 2022 of £452,334 is made up of £301,651 of unrestricted expenditure and £150,683 of restricted expenditure.

___________________

CavanaghKelly, Chartered Accountants & Statutory Auditors Page 23

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023

6. NET INCOME/(EXPENDITURE) FOR THE YEAR

Net income/(expenditure) is stated after charging/(crediting):

6. NET INCOME/(EXPENDITURE) FOR THE YEAR
Net income/(expenditure) is stated after charging/(crediting):
Depreciation
Auditor’s remuneration
7. AUDITORS' REMUNERATION
Auditor’s remuneration
– audit services		 2023
2022
£
£
17,549
17,779
7,441
8,294
24,990
26,073
2023
2022
£
£
7,441
8,294
7,441
8,294

8. STAFF COSTS AND EMPLOYEE BENEFIT

The average number of persons employed by the charitable company during the year was 7 (2022: 6).

The total staff costs and employee benefits were as follows:

e average numer o persons empoye y te cartae compa
6).
The total staff costs and employee benefits were as follows:		 ny urng te year was (:
Gross wages and salaries
Employers national insurance contributions and pension
contributions		 2023
2022
£
£
179,001
152,880
11,817
10,974
190,818
163,854

No employee of the charitable company received total employee benefits of more than £60,000.

8.1. DIRECTORS’ REMUNERATION

The Directors received nor waived any remuneration or any other benefits during the year and no reimbursements of expenses incurred.

__________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 24

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd (Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023

9. PROPERTY, PLANT AND EQUIPMENT

GROUP
Cost
At 31 October 2022
Additions
At 31 October 2023
Depreciation
At 31 October 2022
Charge for year
At 31 October 2023
Carrying amount
At 31 October 2023
At 31 October 2022
CHARITY
Cost
At 31 October 2022
Additions
At 31 October 2023
Depreciation
At 31 October 2022
Charge for year
At 31 October 2023
Carrying amount
At 31 October 2023
At 31 October 2022		 Land and
buildings
£
Office
Equipment
£
IT
Equipment
£
Fixtures and
fittings
£
Motor
Vehicles
£
Total
£
434,545
6,762
46,805
128,530
36,545
653,187
-
414
8,186
-
-
8,600
434,545
7,176
54,991
128,530
36,545
661,787
18,423
6,762
29,389
118,407
29,933
202,914
7,261
30
6,868
3,718
3,450
21,327
25,684
6,792
36,257
122,125
33,383
224,241
408,861
384
18,734
6,405
3,162
437,546
416,122
-
17,416
10,123
6,612
450,273
434,545
6,762
42,415
97,504
22,745
603,971
-
414
8,186
-
-
8,600
434,545
7,176
50,601
97,504
22,745
612,571
18,423
6,762
24,999
88,193
22,745
161,122
7,261
30
6,868
3,390
-
17,549
25,684
6,792
31,867
91,583
22,745
178,671
408,861
384
18,734
5,921
-
433,900
416,122
-
17,416
9,311
-
442,849

__________________

CavanaghKelly, Chartered Accountants & Statutory Auditors Page 25

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023

10. INVESTMENTS

10. INVESTMENTS
Subsidiary
Undertaking
Shares
£
Cost
At 31 October 2022 and 31 October 2023 1
Carrying amount
At 31 October 2023 1
At 31 October 2022 1
10.1 Holdings in subsidiary undertakings
Name Company Details of Proportion held
Registration Investment by Charity
Number
Friends of Charis Limited NI605705 Ordinary 100%

The aggregate amount of capital and reserves and the results of these undertakings for the last relevant financial year were as follows:

Name Year Ended
Capital and
Capital and		 Profit/(loss) Profit/(loss)
Reserves (£) (£)
Friends of Charis Limited 31 October 2023 99,123 45,761
11. RECEIVABLES
Group Charity
2023 2022 2023 2022
£ £ £ £
Trade receivables 234 - 234 -
Other debtors 3,856 5,005 3,856 5,005
Amounts owed by group company - - - 85,846
Prepayments and accrued income 9,482 11,466 8,439 10,423
VAT 2,404 1,914 - -
15,976 18,385 12,529 101,274

12. PAYABLES: Amounts falling due within one year

Trade Payables
Social Security and other taxes
Other Payables
Accruals and Deferred Income		 Group
Charity
2023
2022
2023
2022
£
£
£
£
4,945
2,443
2,247
1,720
6,111
896
5,390
-
1,383
1,127
257
-
6,147
25,540
6,147
25,540
18,586
30,006
14,041
27,260

__________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 26

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd (Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023

13. ANALYSIS OF Funds


or the Year Ended 31 October
3. ANALYSIS OF Funds		 (onnue)
2023
GROUP
Opening balance
Net incoming/(outgoing)
resources
Transfer between funds
Closing Balance
CHARITY
Opening balance
Net incoming/(outgoing)
resources
Transfer between funds
Closing Balance		 Unrestricted Funds
Capital
Funds
Designated
Funds
General
Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
250,000
762,428
189,287
1,201,715
1,284,787
-
-
(28,208)
80,608
52,400
(83,072)
-
-
-
-
-
-
-
250,000
734,220
269,895
1,254,115
1,201,715
Unrestricted Funds
Capital
Funds
Designated
Funds
General Funds
Restricted
Funds
Total Funds
Total Funds
2023
2023
2023
2023
2023
2022
£
£
£
£
£
£
-
250,000
709,066
189,287
1,148,353
1,229,214
-
-
(73,968)
80,608
6,640
(80,861)
-
-
-
-
-
-
-
250,000
635,098
269,895
1,154,993
1,148,353

________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 27

DocuSign Envelope ID: 905AB6F7-F553-49CA-88F7-B56C1C96B4A0

Charis Cancer Care Ltd

(Charitable Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS (Continued) For the Year Ended 31 October 2023

14. ANALYSIS OF NET ASSETS

Unrestricted Funds
Capital Designated
General		 Restricted Total Funds Total Funds
Funds Funds
Funds		 Funds
2023 2023
2023		 2023 2023 2022
£ £
£		 £ £ £
Fixed Assets - -
264,626		 169,275 433,901 442,850
Current Assets - 250,000
384,513		 100,620 735,133 732,763
Current Liabilities - - (14,041) - (14,041) (27,260)
Net Assets - 250,000
635,098		 269,895 1,154,993 1,148,353

15. RELATED PARTY TRANSACTIONS

The charity has availed of the exemption under FRS 102 in relation to the disclosure of transactions with group companies.

16. CONTINGENT LIABILITIES

A contingent liability exists to repay grants received should certain conditions not be fulfilled by the charitable company.

________________ CavanaghKelly, Chartered Accountants & Statutory Auditors Page 28